Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11747346 Biomarkers predictive of cytokine release syndrome

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 2, 2016
Date of Patent
September 5, 2023
Patent Application Number
15757123
Patent Citations
‌
US Patent 7446191 DNA construct encoding CE7-specific chimeric T cell receptor
‌
US Patent 8906682 Methods for treatment of cancer
‌
US Patent 8911993 Compositions for treatment of cancer
‌
US Patent 8916381 Methods for treatment of cancer
‌
US Patent 8975071 Compositions for treatment of cancer
‌
US Patent 9101584 Methods for treatment of cancer
‌
US Patent 9102760 Compositions for treatment of cancer
‌
US Patent 9102761 Compositions for treatment of cancer
‌
US Patent 9394368 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
‌
US Patent 9573988 Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
•••
Patent Inventor Names
Alex Ganetsky
Pamela Shaw
Adam David Cohen
Simon Lacey
Eric Lancaster
David Teachey
Jan J. Melenhorst
Alfred Garfall
Saar Gill
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11747346
Patent Primary Examiner
‌
Mark Halvorson

Find more entities like US Patent 11747346 Biomarkers predictive of cytokine release syndrome

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo